Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Cash from Investing Activities: 2013-2024

Historic Cash from Investing Activities for Wave Life Sciences (WVE) over the last 12 years, with Dec 2024 value amounting to -$938,000.

  • Wave Life Sciences' Cash from Investing Activities rose 35.25% to -$248,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$805,000, marking a year-over-year increase of 33.36%. This contributed to the annual value of -$938,000 for FY2024, which is 15.87% up from last year.
  • As of FY2024, Wave Life Sciences' Cash from Investing Activities stood at -$938,000, which was up 15.87% from -$1.1 million recorded in FY2023.
  • In the past 5 years, Wave Life Sciences' Cash from Investing Activities ranged from a high of -$560,000 in FY2021 and a low of -$1.3 million during FY2020.
  • In the last 3 years, Wave Life Sciences' Cash from Investing Activities had a median value of -$1.1 million in 2023 and averaged -$1.1 million.
  • As far as peak fluctuations go, Wave Life Sciences' Cash from Investing Activities spiked by 65.85% in 2020, and later tumbled by 124.11% in 2022.
  • Wave Life Sciences' Cash from Investing Activities (Yearly) stood at -$1.3 million in 2020, then spiked by 58.15% to -$560,000 in 2021, then slumped by 124.11% to -$1.3 million in 2022, then climbed by 11.16% to -$1.1 million in 2023, then climbed by 15.87% to -$938,000 in 2024.